Skip to main content
Caplight Logo









2A Pharma

2A Pharma

Private
MalmöHealthcare & Life Scienceshttps://2apharma.com/

Last Round

Grant

Sep 27, 2018

Total Funding Raised

$5.96M

Company Overview

2A Pharma is a biopharmaceutical company that develops novel prophylactic and therapeutic vaccines using its proprietary adeno-associated virus-like particle (AAVLP) platform technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalvaccine developmentadeno-associated virus-like particleAAVLPtherapeutic vaccinesprophylactic vaccinesbiotechdrug discoveryclinical-stage biotechvaccine platformnext-generation sequencingNGSphage displayepitope discoverybiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

2A Pharma Comparables

Compare 2A Pharma with similar companies based on industry and business-model similarity.

2A Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VLP Therapeutics
83%
PathoVax LLC
79%
PapiVax Biotech, Inc.
77%

2A Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 27, 2018
SeedJun 25, 2018
SeedDec 20, 2016

Key People

Founding team and executive leadership

John Dirk Vestergaard Nieland

Consultant, COO

Executive Team

2A Pharma Investors

Notable investors and investment history

2A Pharma investors
InvestorRounds
Innovation Fund DenmarkGrant
Eurostars SME programmeGrant
VinnovaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 40% MoM.

  • Mar 4, 2026

    Monthly visitors increased 41% MoM.

2A Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

2A Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about 2A Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersMalmö
Employee Range5
Year Founded2016
Last FundingSep 27, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?